Clinical Trials Directory

Trials / Sponsors / Shanghai Simnova Biotechnology Co.,Ltd.

Shanghai Simnova Biotechnology Co.,Ltd.

Industry · 7 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingF01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus
Lupus Erythematosis
Phase 12024-06-15
RecruitingSNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocr
Recurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma
Phase 12024-04-30
UnknownF01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Phase 12024-04-01
Enrolling By InvitationThe Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
Recurrent Glioblastoma Multiforme (GBM)
Phase 12023-12-26
CompletedAnti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
Phase 12022-07-21
UnknownThe Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
Recurrent Glioblastoma Multiforme
Phase 12022-06-24
UnknownEvaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Phase 12021-03-12